It was a great pleasure to meet with Kimford Meador (Stanford University, Stanford, CA, USA) to discuss the effects and use of antiseizure medications during pregnancy, in women with epilepsy.
The abstract entitled: ‘Fetal Antiseizure Medication Effects on Neuropsychological Outcomes at Age 3 Years in the MONEAD Study’ was presented at the American Academy of Neurology Virtual Annual Meeting 2021.
Questions:
- What is known about the risks to children born to women who use antiseizure medications (ASMs) during pregnancy? (0:16)
- How does pregnancy affect seizure frequency and the need for ASMs? (2:37)
- What is known about the changes in clearance rates of ASMs during pregnancy? (3:40)
Disclosures: Kimford Meador has received grants from NIH/NINDS 2U01-NS038455-11A1, NIH/NINDS R01NS088748-01, Medtronics; Eisai Inc., and Sunovion Pharma; and has been a consultant for the Epilepsy Consortium, Eisai, GW Pharmaceuticals, Medtronics, NeuroPace, Novartis, Supernus, Upsher Smith Labs, UCB Pharma, and Vivus Pharma. Clinical income: EEG procedures and patient care.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of AAN Annual Virtual Meeting 2021.
